MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 21.10.2025
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Diagnostik & Forschung |
Börse |
NYSESPB |
Anteile |
111 M |
Marktkapitalisierung |
$ 19.5 B |
EBITDA (LTM) |
$ 2.05 B |
P/E (LTM) |
20.29 |
P/S (LTM) |
1.82 |
EPS (LTM) |
8.67 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Brainsway Ltd.
BWAY
|
$ 19.29 | -1.73 % | $ 99.4 M | Nasdaq Global Select Market |  Israel |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Castle Biosciences
CSTL
|
$ 40.09 | -0.27 % | $ 1.11 B | Nasdaq Global Market,SPB | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 21.26 | -2.34 % | $ 229 M | Nasdaq Global Market |  China |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
DarioHealth Corp.
DRIO
|
$ 10.04 | -0.99 % | $ 285 M | Nasdaq Capital Market | Israel |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
BioNano Genomics
BNGO
|
$ 1.52 | -0.65 % | $ 1.93 M | Nasdaq Capital Market,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 231.47 | 0.28 % | $ 169 B | NYSE,SPB | USA |
 |
Exact Sciences Corporation
EXAS
|
$ 101.54 | -0.05 % | $ 18.8 B | Nasdaq Capital Market,SPB | USA |
 |
DexCom
DXCM
|
$ 67.42 | 0.84 % | $ 26 B | Nasdaq Global Select Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Fulgent Genetics
FLGT
|
$ 27.01 | -0.55 % | $ 817 M | Nasdaq Global Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
CareDx, Inc
CDNA
|
$ 19.73 | -1.45 % | $ 1.06 B | Nasdaq Global Market,SPB | USA |
 |
Celcuity
CELC
|
$ 102.61 | 0.25 % | $ 4.05 B | Nasdaq Global Select Market | USA |
 |
Anixa Biosciences
ANIX
|
$ 3.42 | 3.64 % | $ 109 K | Nasdaq Capital Market | USA |
 |
Co-Diagnostics
CODX
|
$ 0.24 | -1.79 % | $ 7.04 M | Nasdaq Capital Market | USA |
 |
IQVIA Holdings
IQV
|
$ 226.02 | 0.39 % | $ 41 B | NYSE,SPB | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Guardant Health
GH
|
$ 102.38 | -0.12 % | $ 12.6 B | Nasdaq Global Select Market,SPB | USA |
 |
NeoGenomics
NEO
|
$ 12.3 | -0.97 % | $ 1.56 B | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 7.14 | -0.14 % | $ 1.55 B | Nasdaq Global Select Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 18.81 | -1.05 % | $ 462 M | Nasdaq Global Select Market | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
OPKO Health
OPK
|
$ 1.3 | -0.76 % | $ 902 M | Nasdaq Global Select Market | USA |
 |
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 417.16 | 0.18 % | $ 30.1 B | NYSE,SPB |  Schweiz |
 |
Pacific Biosciences of California
PACB
|
$ 1.88 | 3.3 % | $ 477 M | Nasdaq Global Select Market,SPB | USA |
 |
Illumina
ILMN
|
$ 135.32 | -0.64 % | $ 21.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 203.16 | 0.14 % | $ 10.4 B | NYSE,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 5.1 | - | $ 2.74 M | Nasdaq Global Select Market | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 26.98 | 0.37 % | $ 20 B | NYSE |  Niderland |
 |
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | USA |
 |
Personalis
PSNL
|
$ 8.41 | -0.12 % | $ 498 M | Nasdaq Global Select Market | USA |
|
Biodesix
BDSX
|
$ 6.82 | 1.04 % | $ 884 M | Nasdaq Global Market | USA |
 |
Quidel Corporation
QDEL
|
$ 28.91 | 1.12 % | $ 1.22 B | Nasdaq Global Select Market,SPB | USA |
 |
Precipio
PRPO
|
$ 23.89 | 2.56 % | $ 31 M | Nasdaq Global Select Market | USA |